Results for loratadine translation from Maltese to English

loratadine
loratadine

aerius jew għal loratadine.
to loratadine.

aerius pillola li tinħall fil- ħalq, jew għal loratadine.
orodispersible tablet, or to loratadine.

desloratadine huwa l-metabolu attiv ewlieni ta’ loratadine.
desloratadine is the primary active metabolite of loratadine.

sensittività eċċessiva għas- sustanza attiva jew għal xi sustanzi mhux attivi jew għal loratadine.
hypersensitivity to the active substance, to any of the excipients, or to loratadine.

- jekk inti allerġiku/ a (tbagħti minn sensittività eċċessiva) għal desloratadine, loratadine jew
- if you are allergic (hypersensitive) to desloratadine, loratadine, or to any of the other ingredients

sensittività eċċessiva għas- sustanza attiva jew għal xi sustanzi mhux attivi, għal aġenti adrinerġiċi jew għal loratadine.
hypersensitivity to the active substance, to any of the excipients, to adrenergic agents or to loratadine.

azomyr m’għandux jittieħed minn persuni li jkollhom allerġija għal desloratadine, loratadine jew għal xi sustanza oħra tiegħu.
azomyr must not be used in people who are hypersensitive (allergic) to desloratadine, loratadine or any of the other ingredients.

in-nuqqas ta’ riskju ta’ kanċer intwera bi studji li saru b’desloratadine u loratadine.
the lack of carcinogenic potential was demonstrated in studies conducted with desloratadine and loratadine.

sensittività eċċessiva għas-sustanza attiva, għal xi eċċipjenti elenkati f’ sezzjoni 6.1, jew għal loratadine.
hypersensitivity to the active substance, to any of the excipients listed in section 6.1, or to loratadine.

in-nuqqas ta’ potenzjal li jikkawża l-kanċer intwera bi studji li saru b’desloratadine u loratadine.
the lack of carcinogenic potential was demonstrated in studies conducted with desloratadine and loratadine.

in-nuqqas ta’ potenzjal li jikkawża l-kanċer kien intwera bi studji li saru b’desloratadine u loratadine.
the lack of carcinogenic potential was demonstrated in studies conducted with desloratadine and loratadine.

sensittività eċċessiva għas-sustanza attiva għal kwalunkwe wieћed mill-eċċipjenti elenkati fis- sezzjoni 6.1, jew għal loratadine.
hypersensitivity to the active substance, to any of the excipients listed in section 6.1 or to loratadine.

il-kombinazzjoni ta’ loratadine/pseudoephedrine sulphate li ntużat fi studji b’ħafna dożi u akuti, kien anqas tossiku.
the combination of loratadine/pseudoephedrine sulphate used in acute and multiple-dose studies, exhibited a low order of toxicity.

studji ta’ qabel l-użu kliniku li saru b’desloratadine u loratadine urew li m’hemmx differenzi mill-lat kwalitattiv jew kwantitattiv fil-profil ta’ tossiċità ta’ desloratadine u loratadine f’livelli komparabbli ta’ esponiment għal desloratadine.
non-clinical studies conducted with desloratadine and loratadine demonstrated that there are no qualitative or quantitative differences in the toxicity profile of desloratadine and loratadine at comparable levels of exposure to desloratadine.